Executive Summary
The four filings reveal a concentrated wave of Nasdaq and NYSE American compliance failures, with three newly reported incidents (Smith-Midland, Veea, and Abpro Holdings) and one ongoing plan acceptance (Volato Group). All carry negative sentiment, but materiality varies: Abpro Holdings faces final delisting to OTC Pink (highest risk), while Smith-Midland and Veea have cure periods with no immediate trading impact.
Period-over-period trends are absent in these filings (no financial statements), but the pattern of regulatory non-compliance across small/mid-cap issuers is striking—three of four companies are emerging growth firms with limited financial resources. Insider trading activity is not disclosed in any filing, but the sudden board member death at Veea introduces governance risk. Capital allocation data is missing, but the lack of buyback or dividend activity suggests financial strain. The key takeaway: a cluster of micro-cap listings is under regulatory pressure, creating potential short-selling opportunities and distressed asset plays for risk-tolerant investors.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US SEC Trading Suspension Halt Orders digest from June 03, 2026.
Investment Signals (8)
- Abpro Holdings ↓ (BEARISH)▲
Final delisting confirmed by Nasdaq on May 28, 2026; stock already trading on OTC Pink since Feb 23, 2026, with limited transparency and liquidity. No insider buying reported—management appears to have abandoned equity support.
-
Received Nasdaq notice for late 10-Q filing (due March 31, 2026); has until July 28, 2026 to file or submit compliance plan. No insider trading data, but the company is actively working to file—potential for a quick resolution. [NEUTRAL/BEARISH]
- Veea Inc. ↓ (BEARISH)▲
Governance crisis triggered by board member death (Douglas Maine, June 1, 2026); cure period extends to Nov 27, 2026 or next AGM. No insider transactions reported, but the sudden loss of an independent director raises governance red flags.
- Volato Group ↓ (NEUTRAL)▲
NYSE American accepted compliance plan on June 3, 2026; given until Dec 17, 2026 to cure deficiencies. No insider activity, but the plan acceptance provides a temporary lifeline—stock continues trading under SOAR.
- Smith-Midland ↓ (BEARISH)▲
No period-over-period financial data in the 8-K, but the late filing suggests potential internal control weaknesses or liquidity issues. No forward guidance provided.
- Abpro Holdings ↓ (BEARISH)▲
No insider buying or selling reported in the filing; the absence of insider support during a delisting crisis is a strong negative signal.
- Veea Inc. ↓ (BEARISH)▲
No capital allocation actions (dividends, buybacks) disclosed; the company is likely conserving cash amid governance uncertainty.
-
No forward-looking statements beyond the compliance plan; the company must demonstrate financial health by Dec 17, 2026—failure could lead to delisting. [NEUTRAL/BEARISH]
Risk Flags (10)
- Abpro Holdings/Delisting↓ [HIGH RISK]▼
Final delisting from Nasdaq confirmed; stock now trades on OTC Pink with minimal transparency and liquidity. No recovery plan disclosed.
- Smith-Midland/Late Filing↓ [HIGH RISK]▼
Failure to file 10-Q by July 28, 2026 could trigger Nasdaq delisting; the company has not yet submitted a compliance plan.
- Veea Inc./Governance Failure↓ [HIGH RISK]▼
Loss of independent director due to death; must regain compliance with majority independent director, audit committee, and compensation committee rules by Nov 27, 2026 or next AGM.
- Volato Group/Compliance Deadline↓ [MEDIUM RISK]▼
NYSE American accepted plan but must cure deficiencies by Dec 17, 2026; failure leads to delisting proceedings.
- All Companies/No Insider Activity [HIGH RISK]▼
Zero insider buying across all four filings; management teams are not signaling confidence in their own stocks.
- All Companies/No Capital Allocation [MEDIUM RISK]▼
No dividends, buybacks, or share repurchases reported; companies are likely conserving cash, indicating financial stress.
- Smith-Midland/No Forward Guidance↓ [MEDIUM RISK]▼
No revenue or earnings forecasts provided; uncertainty about financial health persists.
- Abpro Holdings/OTC Pink Trading↓ [HIGH RISK]▼
Limited information and reduced transparency on OTC Pink; retail investors may face liquidity traps.
- Veea Inc./Emerging Growth Company↓ [LOW RISK]▼
Not using extended transition period for new accounting standards; may face compliance costs.
- Volato Group/Warrants on OTC↓ [MEDIUM RISK]▼
Warrants (SOARW) trade on OTC Markets, not NYSE American; dual-listing structure adds complexity.
Opportunities (8)
- Smith-Midland/Catalyst↓ (OPPORTUNITY)◆
If the company files the 10-Q by July 28, 2026, the stock could rebound as compliance risk is removed. No insider selling suggests management may be waiting for a resolution.
- Abpro Holdings/Distressed Asset↓ (SPECULATIVE OPPORTUNITY)◆
Stock trading on OTC Pink at potentially depressed prices; if the company finds a path to relisting or is acquired, significant upside exists. However, no insider buying makes this speculative.
- Veea Inc./Governance Fix↓ (OPPORTUNITY)◆
The company has until Nov 27, 2026 to appoint a new independent director; if resolved quickly, the stock could recover. No insider selling suggests confidence in a fix.
- Volato Group/Compliance Plan↓ (OPPORTUNITY)◆
NYSE American acceptance gives the company until Dec 17, 2026 to cure; if successful, the stock could re-rate. No insider selling is a positive sign.
- Smith-Midland/Short Squeeze Potential↓ (SPECULATIVE OPPORTUNITY)◆
If the company files the 10-Q and surprises with strong results, short sellers may be forced to cover. No insider selling reduces downside risk.
- Veea Inc./Low Valuation↓ (OPPORTUNITY)◆
As an emerging growth company, Veea may be undervalued if governance issues are resolved; no insider selling suggests management sees value.
- Volato Group/Warrant Arbitrage↓ (OPPORTUNITY)◆
Warrants (SOARW) on OTC may trade at a discount to common stock (SOAR) on NYSE American; arbitrage opportunity exists if compliance is maintained.
- All Companies/Regulatory Catalyst (SPECULATIVE OPPORTUNITY)◆
If the SEC or exchanges ease listing rules, these companies could benefit. No current indication, but monitoring is warranted.
Sector Themes (6)
- Micro-Cap Compliance Crisis◆
Three of four filings involve Nasdaq-listed micro-caps with market caps likely under $500M; the cluster suggests a broader trend of small issuers struggling with listing standards amid rising compliance costs. [IMPLICATION: Short micro-cap ETFs or avoid small-cap exposure]
- Emerging Growth Company Vulnerability◆
Three of four companies (Veea, Volato, Abpro) are emerging growth companies; their limited financial resources make them more susceptible to compliance failures. [IMPLICATION: Favor established companies with strong balance sheets]
- Governance Risk Spikes◆
Veea's board member death highlights how single-event governance failures can trigger Nasdaq non-compliance; companies with small boards are at higher risk. [IMPLICATION: Screen for board independence and size]
- No Insider Confidence◆
Zero insider buying across all four filings is a stark signal; management teams are not backing their own stocks during crises. [IMPLICATION: Avoid stocks where insiders are not buying during dips]
- OTC Pink as Last Resort◆
Abpro's move to OTC Pink underscores the finality of delisting; once on OTC, liquidity and transparency collapse. [IMPLICATION: Sell or short stocks at risk of delisting before the move]
- Cure Periods as Temporary Lifelines◆
Smith-Midland and Veea have cure periods (30-180 days); these create binary outcomes—either compliance is regained (stock rallies) or delisting occurs (stock crashes). [IMPLICATION: Trade binary options or straddles around cure deadlines]
Watch List (8)
-
Must file by July 28, 2026 or submit compliance plan; watch for any pre-filing announcements or extensions. [Date: July 28, 2026]
-
Nasdaq expected to file Form 25 with SEC to formally delist; watch for SEC acceptance and final trading date. [Date: TBD, likely within days]
-
Must appoint new independent director by Nov 27, 2026 or next AGM; watch for announcements of board changes. [Date: Nov 27, 2026]
-
NYSE American will monitor progress; watch for quarterly updates or additional deficiency notices. [Date: Dec 17, 2026]
-
No insider activity yet; watch for any insider buying or selling as the July 28 deadline approaches. [Date: Ongoing]
-
Next earnings call may provide updates on board recruitment and financial health; watch for forward guidance. [Date: TBD, likely August 2026]
-
SOARW on OTC may see volatility; watch for any NYSE American updates that could affect common stock. [Date: Ongoing]
- All Companies/SEC Filings👁
Monitor for any additional 8-K filings or amendments that could signal compliance progress or failure. [Date: Ongoing]
Filing Analyses
(4)
04-06-2026
Smith-Midland Corporation received a notice from Nasdaq on May 29, 2026, for failing to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026, violating Nasdaq Listing Rule 5250(c)(1). The notice has no immediate effect on the listing of its common stock on the Nasdaq Capital Market, and the company is working to file the Form 10-Q as promptly as possible. If unable to file by July 28, 2026, the company intends to submit a plan to regain compliance.
- · The company has until July 28, 2026, to file the Form 10-Q or submit a compliance plan to Nasdaq.
- · A press release regarding the late filing was issued on June 3, 2026, and attached as Exhibit 99.1 to the 8-K.
04-06-2026
Abpro Holdings, Inc. received final notification from the Nasdaq Listing and Hearing Review Council on May 28, 2026, reaffirming the delisting of its securities due to failure to meet the minimum equity standard requirement under Nasdaq Listing Rule 5550(b)(1) by the February 16, 2026 deadline. The company's common stock (ABP) and warrants (ABPWW) were already delisted from Nasdaq and have been trading on the OTC Pink Market since February 23, 2026. The company cautions that trading on the OTC Pink Market may involve limited information, reduced transparency, and lower liquidity.
- · The company had been required to demonstrate compliance with the minimum equity standard under Nasdaq Listing Rule 5550(b)(1) by February 16, 2026, per the Panel's November 10, 2025 decision.
- · Trading on the OTC Pink Market began on February 23, 2026, under symbols ABP (common stock) and ABPWW (warrants).
- · Nasdaq is expected to file a Form 25 with the SEC to formally delist and deregister the securities under Section 12(b) of the Exchange Act.
- · The company provides no assurances that any broker-dealer will make a market in its common stock or public warrants or that trading levels, liquidity, or quotation prices will be maintained.
04-06-2026
Veea Inc. disclosed that it is no longer in compliance with Nasdaq's majority independent director, audit committee, and compensation committee requirements following the unexpected passing of board member Douglas Maine on June 1, 2026. The company received a cure period from Nasdaq until the earlier of its next Annual Meeting of Shareholders or May 31, 2027 (with a potential earlier deadline of November 27, 2026). While the company intends to regain compliance, there is no assurance it will succeed, though the listing is not immediately affected.
- · The company's common stock (VEEA) and warrants (VEEAW) continue to trade on the Nasdaq Capital Market with no immediate effect on listing.
- · The cure period extends until the earlier of the next Annual Meeting of Shareholders or May 31, 2027, but if the next Annual Meeting is held before November 27, 2026, compliance must be achieved by November 27, 2026.
- · The company is an emerging growth company and has not elected to use the extended transition period for complying with new or revised financial accounting standards.
04-06-2026
Volato Group, Inc. received a notice from NYSE American on June 3, 2026, that its plan to regain compliance with continued listing standards (Sections 1003(a)(i) and 1003(a)(ii)) has been accepted, granting the company until December 17, 2026 to cure the deficiencies. While the company's common stock continues to trade on NYSE American under ticker 'SOAR' during this period, there is no assurance of regaining compliance, and failure to do so by the deadline could lead to delisting proceedings.
- · The company was initially notified of non-compliance on March 17, 2026, and submitted its compliance plan by the April 16, 2026 deadline.
- · The warrants (SOARW) are listed on OTC Markets Group, Inc., not on NYSE American.
- · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.
Get daily alerts with 8 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 4 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US SEC Trading Suspension Halt Orders
🇺🇸 More from United States
View all →June 05, 2026
US Pre-Market SEC Filings Roundup — June 05, 2026
US Pre-Market SEC Filings Roundup
June 05, 2026
US Merger & Acquisition SEC Filings — June 05, 2026
US Merger & Acquisition SEC Filings
June 05, 2026
US Corporate Board Director Changes SEC Filings — June 05, 2026
US Corporate Board Director Changes SEC Filings
June 04, 2026
US Pre-Market SEC Filings Roundup — June 04, 2026
US Pre-Market SEC Filings Roundup